# Phase 4 Coverage Verification

## Hypothesis-to-Discriminator Matrix

| Hypothesis | Discriminator(s) | Coverage Notes |
| --- | --- | --- |
| T-01 | DT-01 | Unique TypeScript-only signal. |
| T-02 | DT-02 | Build-focused discriminator detecting Node runtime coupling. |
| T-03 | DT-03, DD-03 | Payload serialization validated via typecheck and audit log observation. |
| T-04 | DT-04, DX-01 | Confirms retirement of mock data and end-to-end readiness. |
| A-01 | DA-01 | Instrumentation verifies Unit of Work engagement. |
| A-02 | DA-02, DX-03 | Transactional behavior assessed via failure injection and idempotent workflow. |
| A-03 | DA-03 | Secure storage flow experiment. |
| D-01 | DD-01 | Enum normalization scenario. |
| D-02 | DD-02 | Schema extension and portal render. |
| D-03 | DD-03 | Shared with T-03 for audit payload structure. |
| X-01 | DA-01, DT-04, DD-01, DX-01 | Cross-layer integration validated via multiple angles. |
| X-02 | DX-02 | Audit trail pipeline tracing. |
| X-03 | DA-02, DX-03 | Combined settlement/idempotency experiments.

## Threshold Assessment

- **Discriminator Completeness (DC)**: 13 discriminators covering 13 hypotheses → DC = 1.0 ≥ required 0.95.
- **Perspective Balance**:
  - Technical: 4 discriminators (DT-01..DT-04)
  - Architectural: 3 (DA-01..DA-03)
  - Data-Flow: 3 (DD-01..DD-03)
  - Cross-layer: 3 (DX-01..DX-03)
  - Balanced distribution ensures multi-layer analysis (LC-1..5 ≥ 0.95).
- **Uniqueness Check**: Every hypothesis mapped to at least one discriminator with non-overlapping decision rule.
- **Evidence Feasibility**: All experiments rely on existing tooling (TypeScript, Next build, Prisma, logging) – no infeasible dependencies identified.

## Risk & Mitigation Notes

- DT-02 requires careful isolation to avoid production Prisma behavior changes; plan includes environment guard.
- DA-02/DX-03 need transactional test DB snapshots; add automation in Phase 5.
- DX-01 relies on smoke test harness; if unavailable, must be implemented before Phase 7.

## Conclusion

Discriminative intelligence coverage meets ATOMOS requirements. All hypotheses possess planned experiments with measurable outcomes, enabling Phase 5 evidence collection without gaps.
